Change Language
Niranib 100mg Cap  (Niraparib Cap)
Niranib 100mg Cap  (Niraparib Cap)
Niranib 100mg Cap  (Niraparib Cap)
Niranib 100mg Cap  (Niraparib Cap)
Niranib 100mg Cap  (Niraparib Cap)
Niranib 100mg Cap  (Niraparib Cap)

Niranib 100mg Cap (Niraparib Cap)

Price 38000.0 INR/ Unit

MOQ : 1 Unit

Niranib 100mg Cap (Niraparib Cap) Specification

  • Indication
  • Indicated for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to platinum-based chemotherapy
  • Origin of Medicine
  • India
  • Salt Composition
  • Niraparib 100mg
  • Pacakaging (Quantity Per Box)
  • 30 Capsules per box
  • Dosage Form
  • Capsule
  • Brand Name
  • Niranib
  • Packaging Type
  • Blister Pack
  • Life Span
  • 24 months from manufacturing date
  • Drug Type
  • Prescription only
  • Ingredients
  • Niraparib Tosylate Monohydrate
  • Physical Form
  • Capsule
  • Function
  • Antineoplastic (PARP Inhibitor)
  • Recommended For
  • Ovarian Cancer Patients
  • Dosage
  • 100mg once daily or as directed by physician
  • Dosage Guidelines
  • Take as prescribed by a registered medical practitioner
  • Suitable For
  • Adults only
  • Quantity
  • 30 Capsules
  • Storage Instructions
  • Store below 30C, protect from moisture and light
  • Pregnancy Category
  • Not recommended during pregnancy
  • Contraindications
  • Hypersensitivity to Niraparib
  • Warning
  • To be sold by retail on the prescription of an oncologist only
  • Side Effects
  • Fatigue, nausea, abdominal pain, anemia, thrombocytopenia, constipation
  • Marketed By
  • Zydus Oncosciences
  • Therapeutic Class
  • Oncology
  • Regulatory Approval
  • WHO-GMP approved
  • Minimum Order Quantity
  • 1 box
  • Colour
  • White and blue capsule
  • Batch No.
  • As per packaging
  • Route of Administration
  • Oral
 
 

Niranib 100mg Cap (Niraparib Cap) About

Description

Niraparib is used as first-line maintenance treatment of advanced ovarian cancer, fallopian tube cancer, or primary peritoneal cancer in patients with a certain type of inherited (germline) abnormal BRCA gene or a positive tumor test for genomic instability called homologous recombination deficiency (HRD). It is also used as maintenance treatment of recurrent (cancer that comes back) ovarian cancer, fallopian tube cancer, or primary peritoneal cancer in patients with a certain type of inherited (germline) abnormal BRCA gene. Your doctor will test for the presence of this gene (deleterious or suspected deleterious germline BRCA gene) and genomic instability. This medicine is used in patients who have had received platinum-based cancer medicines.

This medicine is available only with your doctor's prescription.

Before Using

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.



A Targeted Therapy for Ovarian Cancer

Niranib 100mg Cap is an advanced oral therapy crafted for individuals recovering from ovarian, fallopian tube, or primary peritoneal cancer. It serves as a maintenance treatment, helping prolong remission following platinum-based chemotherapy. Its formulation as a PARP inhibitor enables it to hinder cancer cell repair mechanisms, offering significant therapeutic benefits to eligible patients.


Strict Prescription and Administration

This medication should only be taken under the prescription of an oncologist and in accordance with their guidance. The standard dosage is 100mg once daily, though this may vary based on individual medical conditions. Usage beyond the prescribed limits, or by those under 18 years of age or pregnant women, is not recommended.


Quality Assurance and Storage Guidelines

Each box contains 30 capsules, presented in a reliable blister pack for convenience and protection. Manufactured in India and WHO-GMP approved, Niranib upholds high regulatory standards. To ensure maximum efficacy and safety, store the product below 30C, shielded from moisture and direct light, and adhere to the given shelf-life.

FAQ's of Niranib 100mg Cap (Niraparib Cap):


Q: How should Niranib 100mg Cap be administered?

A: Niranib 100mg Cap should be taken orally, typically once daily, exactly as instructed by a registered oncologist. Swallow the capsule whole with a glass of water, and do not crush or chew it.

Q: What is the main benefit of using Niranib for patients?

A: Niranib is primarily indicated for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer. It helps reduce the risk of cancer recurrence following a positive response to platinum-based chemotherapy.

Q: When is Niranib therapy recommended?

A: Niranib is recommended for adult patients who are in a complete or partial response to platinum-based chemotherapy for ovarian, fallopian tube, or primary peritoneal cancer, as part of their ongoing maintenance therapy.

Q: Where should Niranib capsules be stored after purchase?

A: Niranib capsules must be stored below 30C, in a dry environment away from direct sunlight and moisture, to maintain their potency and effectiveness throughout their 24-month shelf life.

Q: What are common side effects of Niranib 100mg Cap?

A: Possible side effects include fatigue, nausea, anemia, abdominal pain, thrombocytopenia, and constipation. Patients experiencing severe symptoms should consult their oncologist promptly.

Q: Who should not use Niranib 100mg Cap?

A: This medication should not be used by individuals with a known hypersensitivity to Niraparib or its ingredients, nor is it recommended during pregnancy. It is only suitable for adults as prescribed by a qualified medical practitioner.

Q: What process should I follow to obtain Niranib 100mg Cap?

A: Niranib is a prescription-only medicine and can be obtained from licensed pharmacies or suppliers in India with a valid prescription from an oncologist. The minimum order is one box, containing 30 capsules.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Pharmaceutical Capsules Category

Koselugo 10mg Capsule

Koselugo 10mg Capsule

Price 400000.0 INR / Unit

Minimum Order Quantity : 1 Unit

Physical Form : Other, Capsule

Storage Instructions : Store below 30C in a dry place, protect from light

Salt Composition : Selumetinib 10mg

Origin of Medicine : Imported

Ibrutinib 140 Mg Capsules

Ibrutinib 140 Mg Capsules

Price 2600 INR / Unit

Minimum Order Quantity : 10 Units

Physical Form : Other, Capsule

Storage Instructions : Store at room temperature (1530C) away from moisture and direct sunlight

Salt Composition : Ibrutinib 140 mg

Origin of Medicine : Synthetic

Lenalid 10 Mg Lenalidomide

Lenalid 10 Mg Lenalidomide

Price 3838 INR / Unit

Minimum Order Quantity : 10 Units

Physical Form : Other, Tablet

Storage Instructions : Store in a cool dry place away from direct sunlight

Salt Composition : Lenalidomide

Origin of Medicine : Synthetic

Erleada 60mg (Apalutamide )

Erleada 60mg (Apalutamide )

Price 125000.0 INR / Bottle

Minimum Order Quantity : 1 Bottle

Physical Form : Capsules

Storage Instructions : Cool & Dry Place



Back to top